Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees

Author:

Inoue Takeshi1ORCID,Shinnakasu Ryo123ORCID,Kawai Chie1ORCID,Yamamoto Hiromi1ORCID,Sakakibara Shuhei4ORCID,Ono Chikako56ORCID,Itoh Yumi7ORCID,Terooatea Tommy8ORCID,Yamashita Kazuo8ORCID,Okamoto Toru7ORCID,Hashii Noritaka9ORCID,Ishii-Watabe Akiko9ORCID,Butler Noah S.10ORCID,Matsuura Yoshiharu56ORCID,Matsumoto Hisatake11ORCID,Otsuka Shinya12ORCID,Hiraoka Kei12ORCID,Teshima Takanori1314ORCID,Murakami Masaaki151617ORCID,Kurosaki Tomohiro11819ORCID

Affiliation:

1. Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan 1

2. Division of Medical Research Support, Advanced Research Support Center, Ehime University, Ehime, Japan 2

3. Translational Research Center, Ehime University Hospital, Ehime, Japan 3

4. Laboratory of Immune Regulation, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan 4

5. Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 5

6. Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan 6

7. Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 7

8. KOTAI Biotechnologies, Inc., Osaka, Japan 8

9. Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japan 9

10. Department of Microbiology and Immunology, The University of Iowa, Iowa City, IA, USA 10

11. Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan 11

12. Department of Surgery, National Hospital Organization Hakodate National Hospital, Hokkaido, Japan 12

13. Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan 13

14. Department of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan 14

15. Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan 15

16. Team of Quantum immunology, Institute for Quantum Life Science, National Institute for Quantum and Radiological Science and Technology, Chiba, Japan 16

17. Division of Molecular Neuroimmunology, Department of Homeostatic Regulation, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan 17

18. Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan 18

19. Laboratory for Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan 19

Abstract

In contrast to a second dose of the SARS-CoV-2 mRNA vaccine, a third dose elicits potent neutralizing activity against the Omicron variant. To address the underlying mechanism for this differential antibody response, we examined spike receptor-binding domain (RBD)–specific memory B cells in vaccinated individuals. Frequency of Omicron-reactive memory B cells increased ∼9 mo after the second vaccine dose. These memory B cells show an altered distribution of epitopes from pre-second memory B cells, presumably due to an antibody feedback mechanism. This hypothesis was tested using mouse models, showing that an addition or a depletion of RBD-induced serum antibodies results in a concomitant increase or decrease, respectively, of Omicron-reactive germinal center (GC) and memory B cells. Our data suggest that pre-generated antibodies modulate the selection of GC and subsequent memory B cells after the second vaccine dose, accumulating more Omicron-reactive memory B cells over time, which contributes to the generation of Omicron-neutralizing antibodies elicited by the third vaccine dose.

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Quantum LEAP Flagship Program

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3